Abstract:Introduction : The proliferation of heterogeneous clones in multiple myeloma (MM) cells is associated with progression and resistance to treatments. Chromosomal abnormalities (CAs) were one of the drivers of myeloma progression and resistance mechanisms for the treatment. Here, we developed the method of simultaneous detection of five CAs in single cell by seven colors-fluorescent in situ hybridization (FISH). With this FISH analysis, we analyzed the acquisition patterns of CAs and the relationships between complex CAs with treatment response and prognosis. Methods: Patients diagnosed as MM who provided written informedconsent to participate in the study were enrolled. All the patients were treated with three or more drug-combined treatments based on proteasome inhibitors and/or IMiDs between 2014 and 2022 in our institution. Bone marrow aspiration and biopsy were performed at the time of diagnosis and upon disease progression. Myeloma cells were isolated from bone marrow samples using anti-CD138-MicroBeads. These cells were spotted on the slide glasses. After fixation and permeabilization, cells were hybridized with 7 series of probes simultaneously to detect targeted five CAs, 1q gain, del(17p), t(11;14), t(14;18), and t(4;14). The fluorescent signals were detected by confocal microscopy (ZEISS, LSM880) (Figure 1). We counted 100 or more cells in each patient and calculated the positive ratio of the five series of CAs. The relationships between each combination of CAs and non-complete response (non-CR) status were analyzed by Mann-Whitney test. The event free survival (EFS) was analyzed by Kaplan-Meier and the significant relationships were calculated by log-rank test. EFS were estimated from the start of the treatment to the days of progression, start of next treatment, or death. This protocol was approved by the institutional review board of Japanese Foundation for Cancer Research. Result: The enrolled patients were 41 including 24 newly diagnosed (ND) and 17 relapse and refractory (RR) patients. The median age was 65.8 years (40-85) in ND patients and 70.3 years (50-85) in RR patients. In ND patients, the presence of del(17p) with t(11;14) (58%; 14/24), 1q gain with t(11;14) (50%; 12/24), and t(4;14) with t(14;16) (50%; 12/24) were frequently observed. Double positivity of t(11;14) and t(14;16) alone or in combination with other CAs and t(11;14) and del(17p) alone were associated with non-CR ( P<0.035 and P<0.041, respectively). Furthermore, patients with t(11;14) and t(14;16) alone had lower EFS (HR 5.829, 95%CI;1.539-22.07) (Table 1). In RR patients, the double positivity of del(17p) and 1q gain increased to 88% (15/17) compared to 42% (10/24) in ND patients. The double positivity of t(14;16) and t(4;14) alone or with other CAs, and triple positive CAs were associated with non-CR, ( P=0.048, and 0.037, respectively). Patients with 1q gain and t(4;14) alone or with other CAs (HR 6.977, 95%CI;1.464-33.26 ) and triple positive CAs had lower EFS (HR 7.781, 95%CI; 0.98-61.76); Among triple positive CAs, the combination of 1q gain, del(17p), and t(4;14) (HR 5.871, 95%CI; 1.442-23.9), as well as the combination of 1q gain, del(17p), and t(14;16) (HR 4.363 95%CI; 1.189-16) were related to lower EFS (Table 1). Conclusion: The simultaneous FISH analysis in single cells is useful for detecting the acquisition-pattern of CA in myeloma. This method is also useful even in low numbers of myeloma cells. The single CA does not always correlate to the treatment response or prognosis. The detection of the combined acquisition of CAs might be provided a novel prognosis factor.

Detection of Chromosomes 5 and 7 Aberrations in Myelodysplastic Syndromes Using Dual-Color Fluorescence in Situ Hybridization

Chromosomes 5, 7 and 8 abnormalities in myelodysplastic syndromes by using interphase fluorescence in situ hybridization

Detecting the abnormity of chromosomes 8 and 20 aberrations in myelodysplastic syndromes by using fluorescence in situ hybridization

[Cytogenetic and Clinical Analysis of -7/7Q- Abnormalities in Acute Leukemia and Myelodysplastic Syndrome].

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

[A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Cytogenetic Abnormalities Predict Disease Progression in Primary Myelodysplastic Syndrome: A Multicentric Study in 508 Chinese Patients.

[Cytogenetic Analysis on 135 Cases of Chronic Myelogenous Leukemias with Non-Simple Philadelphia Chromosome].

[Analysis of 32 Cases of Acute Leukemia with Abnormality of Chromosome 7].

Application Of Dual Fusion Interphase Fluorescence In Situ Hybridization Probe To The Detection Of Minimal Residual Disease In Chronic Myeloid Leukemia

Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes

[Identification of Complex Chromosomal Aberrations in Acute Leukemia by Using Conventional Cytogenetics Combined with Multiplex Fluorescence in Situ Hybridization].

The Seven-Color FISH Analysis Can Detect the Acquisition Pattern of Complex Chromosomal Abnormalities Related to Poor Response and Prognosis in Patients with Multiple Myeloma

[Fluorescence in Situ Hybridization Identifies Complex Chromosomal Aberrations in Multiple Myeloma].

Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma

Prognostic Power of Abnormal Cytogenetics for Multiple Myeloma: a Multicenter Study in China.

Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.

[Detection of Bcr/abl Fusion Gene by Dual Color-Dual Fusion Fluorescence in Situ Hybridization].

Application of Dual-Color Fluorescence in Situ Hybridization in Acute Myeloid Leukemia with T(8;21)